Independent · evidence-based · non-judgmentalDraft · pending medical review
Not yet medically reviewed — information on this site is in preparation and has not been verified by a medical reviewer.
Drug index / Empathogen / Mephedrone (4-MMC)
Empathogen

Mephedrone (4-MMC)

2-(methylamino)-1-(4-methylphenyl)propan-1-one

Mephedrone (4-MMC) is a synthetic cathinone stimulant chemically related to the khat plant's active compound. It produces MDMA- and cocaine-like effects — euphoria, energy, and sociability — but carries serious risks including sympathomimetic toxicity and a strong urge to redose.

Overview

Mephedrone, also called 4-methylmethcathinone or 4-MMC, is a synthetic stimulant of the cathinone class. Cathinones are chemically related to the natural stimulant found in the khat plant (Catha edulis) of East Africa; mephedrone is a laboratory-made member of this family and a beta-keto analogue of an amphetamine. It first appeared on the recreational drug market around 2007-2009, sold online and in "head shops" as a legal alternative to MDMA (ecstasy) and cocaine, and became widely used before being banned. It usually comes as a white or off-white powder or in capsules, and people typically swallow it, wrap it in paper and swallow it ("bombing"), or snort it; injecting also occurs and is especially dangerous. Common street names include drone, M-CAT, meow meow, and bubble.

Source: EMCDDA/Europol Joint Report; peer-reviewed pharmacology literature

Chemistry & mechanism of action

Mephedrone works by acting on the brain's monoamine systems — the same broad targets as MDMA, amphetamines, and cocaine. It is a non-selective monoamine releaser and reuptake inhibitor, meaning it both triggers release of and blocks the reabsorption of dopamine, norepinephrine, and serotonin. Its balance between dopamine and serotonin effects (a dopamine-to-serotonin transporter ratio of roughly 1.4) sits between that of cocaine and MDMA, which is why users often describe it as a mixed "MDMA-cocaine-like" drug — part euphoric stimulant, part empathogen. In this respect it acts as a releaser, similar to methylone, and differently from MDPV, which mainly blocks reuptake without triggering release. Its effects come on quickly and are relatively short-lived, which contributes to the strong tendency to redose.

Source: peer-reviewed pharmacology literature

Effects

People report that mephedrone produces euphoria, increased energy and alertness, talkativeness, feelings of warmth and closeness to others, and heightened sociability — an effect profile overlapping ecstasy and cocaine. Onset is rapid and the main effects are short-lasting, often less than an hour, which drives a strong and well-documented urge to take repeated doses in a session. Common unwanted effects include jaw clenching, teeth grinding, sweating, dilated pupils, raised heart rate and blood pressure, agitation, and difficulty sleeping.

Source: peer-reviewed pharmacology literature; EMCDDA/Europol Joint Report

Risks & harms

Mephedrone's central risks come from over-stimulation of the cardiovascular and nervous systems (sympathomimetic toxicity): rapid or irregular heartbeat, chest pain, dangerously high blood pressure, overheating, agitation, and, in severe cases, seizures. Because effects are short and intense, compulsive redosing is common and raises the total dose and the strain on the body. At least 90 deaths have been documented in which mephedrone alone or combined with other substances was implicated, and the risk climbs sharply when it is mixed with other stimulants, alcohol, or depressants, or when it is injected. Repeated heavy use is associated with anxiety, paranoia, low mood, and dependence. As with other cathinones sold as powders, actual purity and contents vary and a product sold as one cathinone may be another.

Source: peer-reviewed pharmacology literature; EMCDDA/Europol Joint Report

Images

Visual references coming soon.

If it’s too intense

If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.

  • Get to a calm, safe space with someone you trust who is sober and can stay with you.
  • Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
  • Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
  • Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
  • A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
  • Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.

After MDMA, overheating and over-hydration are both dangerous: cool down, and sip to thirst rather than gulping water (forcing plain water can drop your blood sodium dangerously).

Call 911 (or Poison Control, 1-800-222-1222) right away for chest pain, a very high body temperature, a seizure, unconsciousness, or severe confusion. These are medical emergencies, not something to wait out.

Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.

Forensic dossier

Draft · every field is source-cited or marked “Unknown — pending review”

Identity

IUPAC name
2-(methylamino)-1-(4-methylphenyl)propan-1-onePubChem PUG-REST · retrieved 2026-06-18
SMILES
CC1=CC=C(C=C1)C(=O)C(C)NCPubChem PUG-REST · retrieved 2026-06-18
InChIKey
YELGFTGWJGBAQU-UHFFFAOYSA-NPubChem PUG-REST · retrieved 2026-06-18
Synonyms / aliases
4-mmc, meow meow, mephedrone, 4-methylmethcathinone, Meow meow, 4-MMC, M-CAT, 4-methylephedrone, bk-4-methylmethamphetamine, MMCAT compound, 4-MMC compound, BubblesPubChem PUG-REST + seed aliases · retrieved 2026-06-18

Composition

Composition
N/A — single compound (see Identity)

Physical / pill characteristics

Dosage form
Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
Route
Unknown — pending review
Shape
Unknown — pending review
Color
Unknown — pending review
Imprint
Unknown — pending review
Score
Unknown — pending review

Scheduling & legal status

US schedule
Unknown — pending review
International
See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA · retrieved 2026-06-18

Effects

Effects
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Risks

Risks
Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus · retrieved 2026-06-18

Interactions

Interactions
Unknown — pending review

Dosage

Pending medical reviewer

Sources

← Back to the drug index